Conning Inc. Merck & Co., Inc. Transaction History

Conning Inc.

$2.89 Billion
Q3 2024

A detailed history of Conning Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Conning Inc. holds 36,473 shares of MRK stock, worth $3.58 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

36,473

Previous 36,685 0.58%

Holding current value

$3.58 Million

Previous $4.54 Million 8.81%

% of portfolio

0.14%

Previous 0.17%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$111.15 - $128.97 $23,563 - $27,341	-212 Reduced 0.58%	36,473 $4.14 Million
Q2 2024 Jul 26, 2024	BUY	$123.8 - $132.96 $56,824 - $61,028	459 Added 1.27%	36,685 $4.54 Million
Q1 2024 Apr 26, 2024	SELL	$113.24 - $131.95 $286,383 - $333,701	-2,529 Reduced 6.53%	36,226 $4.78 Million
Q4 2023 Jan 29, 2024	BUY	$100.18 - $109.02 $2,003 - $2,180	20 Added 0.05%	38,755 $4.23 Million
Q3 2023 Oct 26, 2023	SELL	$102.95 - $114.33 $263,140 - $292,227	-2,556 Reduced 6.19%	38,735 $3.99 Million
Q2 2023 Jul 21, 2023	SELL	$108.61 - $118.38 $15,314 - $16,691	-141 Reduced 0.34%	41,291 $4.76 Million
Q1 2023 Apr 27, 2023	SELL	$102.94 - $114.86 $5.94 Million - $6.63 Million	-57,728 Reduced 58.22%	41,432 $4.41 Million
Q4 2022 Feb 07, 2023	BUY	$87.44 - $112.11 $5.01 Million - $6.42 Million	57,262 Added 136.67%	99,160 $11 Million
Q3 2022 Oct 28, 2022	SELL	$84.53 - $94.96 $171,088 - $192,199	-2,024 Reduced 4.61%	41,898 $3.61 Million
Q2 2022 Jul 20, 2022	SELL	$83.49 - $94.64 $11,187 - $12,681	-134 Reduced 0.3%	43,922 $4 Million
Q1 2022 May 02, 2022	SELL	$73.51 - $82.4 $3,896 - $4,367	-53 Reduced 0.12%	44,056 $3.62 Million
Q4 2021 Jan 27, 2022	SELL	$72.28 - $90.54 $20,672 - $25,894	-286 Reduced 0.64%	44,109 $3.38 Million
Q3 2021 Nov 05, 2021	SELL	$71.68 - $78.83 $395,673 - $435,141	-5,520 Reduced 11.06%	44,395 $3.34 Million
Q2 2021 Jul 29, 2021	SELL	$70.31 - $77.77 $268,513 - $297,003	-3,819 Reduced 7.11%	49,915 $3.88 Million
Q1 2021 Apr 23, 2021	SELL	$68.86 - $81.11 $39.1 Million - $46.1 Million	-568,518 Reduced 91.36%	53,734 $4.14 Million
Q4 2020 Jan 28, 2021	BUY	$71.77 - $79.65 $4.96 Million - $5.51 Million	69,158 Added 12.5%	622,252 $50.9 Million
Q3 2020 Oct 21, 2020	SELL	$73.18 - $82.95 $1.29 Million - $1.47 Million	-17,686 Reduced 3.1%	553,094 $45.9 Million
Q2 2020 Aug 07, 2020	SELL	$70.42 - $80.13 $1.68 Million - $1.91 Million	-23,867 Reduced 4.01%	570,780 $44.1 Million
Q1 2020 Apr 29, 2020	BUY	$63.36 - $87.82 $1.38 Million - $1.92 Million	21,816 Added 3.81%	594,647 $45.8 Million
Q4 2019 Jan 29, 2020	BUY	$77.58 - $87.54 $2.66 Million - $3 Million	34,287 Added 6.37%	572,831 $52.1 Million
Q3 2019 Oct 30, 2019	SELL	$76.08 - $82.93 $2.45 Million - $2.67 Million	-32,231 Reduced 5.65%	538,544 $45.3 Million
Q2 2019 Jul 25, 2019	SELL	$69.84 - $81.59 $3.15 Million - $3.68 Million	-45,131 Reduced 7.33%	570,775 $47.9 Million
Q1 2019 Apr 22, 2019	SELL	$69.58 - $79.36 $2.47 Million - $2.82 Million	-35,495 Reduced 5.45%	615,906 $51.2 Million
Q4 2018 Jan 29, 2019	SELL	$65.24 - $75.71 $6.59 Million - $7.64 Million	-100,937 Reduced 13.42%	651,401 $49.8 Million
Q3 2018 Oct 26, 2018	SELL	$57.69 - $67.84 $4.75 Million - $5.58 Million	-82,324 Reduced 9.86%	752,338 $53.4 Million
Q2 2018 Jul 25, 2018	BUY	$50.83 - $59.72 $678,987 - $797,739	13,358 Added 1.63%	834,662 $50.7 Million
Q1 2018 May 04, 2018	BUY	$50.96 - $59.23 $5.37 Million - $6.24 Million	105,349 Added 14.71%	821,304 $44.7 Million
Q4 2017 Jan 30, 2018	BUY	$51.62 - $61.64 $4.88 Million - $5.83 Million	94,610 Added 15.23%	715,955 $40.3 Million
Q3 2017 Oct 20, 2017	BUY	$58.67 - $63.13 $36.5 Million - $39.2 Million	621,345	621,345 $39.8 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.

Account